BGB-8035
Product Specifications
CAS Number
2283349-24-4
Target
BTK|||EGFR
Related Pathways
JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors
Purity
0.9674
Bioactivity
BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.
Smiles
C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4
Molecular Formula
C24H31N5O4
Molecular Weight
453.53
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15424633 25 µL (1x 25 µL)
IRFP-luciferase lentivirus (PGK, Puro) - iRFP-luciferase lentivirus (PGK, Puro)
Ask
View Details 
MBS6383735-01 0.1 mL
KLK3 (APS, Prostate-specific Antigen, PSA, Gamma-seminoprotein, Seminin, Kallikrein-3, P-30 Antigen, Semenogelase) (MaxLight 490)
Ask
View Details 
MBS6383735-02 5x 0.1 mL
KLK3 (APS, Prostate-specific Antigen, PSA, Gamma-seminoprotein, Seminin, Kallikrein-3, P-30 Antigen, Semenogelase) (MaxLight 490)
Ask
View Details